04/01/2015
This article was translated by an automatic translation system, and was therefore not reviewed by people.
transparent image
ANVISA ordered the suspension, throughout the national territory, manufacturing, distribution, dissemination, marketing and use of all lots and all products manufactured by the company Kraemer Laboratory Ltda.
The company was considered unsatisfactory for the production of drugs to enter at odds with the Good Manufacturing Practices of pharmaceutical products. The company also marketed unregistered products with ANVISA.
The measure is in Resolution No. 980, published on Monday (30/3) in the Official Gazette (DOU). The standard ratified Resolution No. 2,330 / 14 on the subject.
The company will promote the collection of existing stocks in the market.
Check the resolution in the Official Gazette
Source: ANVISA
To access the ANVISA site, click here.
Our news are taken in full of our partner sites. For this reason, we can not change their content even in cases of typos. transparent image
This article was translated by an automatic translation system, and was therefore not reviewed by people.